SCHEMBL21834564

SCHEMBL21834564

Cc1n[nH]cc1-c1csc(CNC(=O)OC(C)(C)C)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.48
HDAC1 Q13547 3/20 0.48
HDAC6 Q9UBN7 3/20 0.48
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
PI4KB Q9UBF8 1/20 0.38
GFER P55789 2/20 0.37
BPGM P07738 1/20 0.37
KDM4A O75164 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CACNA1H O95180 1/20 0.35
CACNA1B Q00975 1/20 0.35
CACNA1C Q13936 1/20 0.35
CYP1A2 P05177 1/20 0.35
PDPK1 O15530 1/20 0.34
DYRK1A Q13627 1/20 0.33
PARP1 P09874 1/20 0.33
HSD17B10 Q99714 1/20 0.33
BCHE P06276 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21834617 0.82 HDAC3 (0.45) HDAC3HDAC1HDAC6KDM4ELMNA
SCHEMBL21834625 0.81 HDAC3 (0.42) HDAC3HDAC1HDAC6KDM4ELMNA
SCHEMBL21834677 0.80 HDAC3 (0.42) HDAC3HDAC1HDAC6L3MBTL1DYRK1A
SCHEMBL21812752 0.80 HDAC3 (0.48) HDAC3HDAC1HDAC6KDM4ELMNA
SCHEMBL21834557 0.79 HDAC3 (0.41) HDAC3HDAC1HDAC6KDM4ELMNA
SCHEMBL21812556 0.78 HDAC3 (0.48) HDAC3HDAC1HDAC6KDM4ELMNA
SCHEMBL21812974 0.78 HDAC1 (0.48) HDAC3HDAC1HDAC6KDM4EKDM4A
SCHEMBL19114635 0.78 HDAC3 (0.60) HDAC3HDAC1HDAC6PI4KBKDM4A
SCHEMBL16020352 0.78 HDAC3 (0.48) HDAC3HDAC1HDAC6KDM4ELMNA
SCHEMBL21812678 0.76 MAPK1 (0.53) HDAC3HDAC1HDAC6LMNAKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020064175-A1 INDANE DERIVATIVES FOR USE IN THE TREATMENT OF BACTERIAL INFECTION ANTABIO SAS (FR) 2020-04-02 WO disclosed